Urinary excretion kinetics of 177Lu-PSMA

被引：0
|
作者：
de Bakker, M. [1 ]
Dominicus, N. [1 ]
Meeuwis, A. [1 ]
Janssen, M. J. R. [1 ]
Konijnenberg, M. W. [1 ,2 ]
Nagarajah, J. [1 ]
Peters, S. M. B. [1 ]
机构：
[1] Radboudumc, Nijmegen, Netherlands
[2] Erasmus MC, Rotterdam, Netherlands
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2022年 / 49卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-102
引用
收藏
页码：S36 / S36
页数：1
相关论文
共 50 条
  • [41] Performance study of a 360° CZT camera for monitoring 177Lu-PSMA treatment
    Vergnaud, Laure
    Badel, Jean-Noel
    Giraudet, Anne-Laure
    Kryza, David
    Mognetti, Thomas
    Baudier, Thomas
    Rida, Hanan
    Dieudonne, Arnaud
    Sarrut, David
    EJNMMI PHYSICS, 2023, 10 (01)
  • [42] Prostate Cancer With Neuroendocrine Differentiation Recurring After Treatment With 177Lu-PSMA A Chance for 177Lu-DOTATATE Therapy?
    Nesari Javan, Farnaz
    Aryana, Kamran
    Askari, Emran
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (09) : E480 - E482
  • [43] Assessing Response to 177Lu-PSMA Radioligand Therapy Using Modified PSMA PET Progression Criteria
    Michalski, Kerstin
    Klein, Claudius
    Brueggemann, Tonio
    Meyer, Philipp T.
    Jilg, Cordula Annette
    Ruf, Juri
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (12) : 1741 - 1746
  • [44] Pre- or Post-Chemotherapy: Effect of 177Lu-PSMA Radioligand Therapy on PSMA Expression
    Yadav, Surekha
    Heath, Courtney Lawhn
    Juarez, Roxanna
    De Kouchkovsky, Ivan
    Aggarwal, Rahul
    Hope, Thomas
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [45] Perspective on 177Lu-PSMA Therapy for Metastatic Castration-Resistant Prostate Cancer
    Kwekkeboom, Dik
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (07) : 1002 - 1003
  • [46] 177Lu-PSMA for Extended Treatment of Metastatic Castration-Resistant Prostate Cancer
    Derlin, Thorsten
    Widjaja, Liam
    Werner, Rudolf A.
    Bengel, Frank M.
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (01) : 54 - 58
  • [47] Evaluation of the contamination risk during 177Lu-PSMA therapy of advanced prostate cancer
    Brosch-Lenz, Julia
    Nekolla, Stephan
    Tischendorf, Luisa
    Allmann, Jakob
    Weber, Wolfgang
    Eiber, Matthias
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [48] Radionuclide Therapy With 177Lu-PSMA in a Case of Metastatic Adenoid Cystic Carcinoma of the Parotid
    Simsek, Duygu Has
    Kuyumcu, Serkan
    Agaoglu, Fulya Yaman
    Unal, Seher Nilgun
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (09) : 764 - 766
  • [49] Is 177Lu-PSMA an effective treatment modality for mCRPC patients with bone and visceral metastasis?
    Gupta, Manoj
    Karthikeyan, G.
    Choudhury, Partha Sarathi
    Sharma, Anurag
    Singh, Amitabh
    Rawal, Sudhir
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2020, 23 (03) : 312 - 320
  • [50] Influence of patient motion on image-based dosimetry for 177Lu-PSMA therapy
    Resch, S.
    Rumiantcev, M.
    Liubchenko, G.
    Brendel, M.
    Ziegler, S. I.
    Boening, G.
    Delker, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S211 - S211
12345